This site is intended for health professionals only

Published on 6 December 2011

Share this story:

TOPRA: ‘Patients help benefit—risk decisions’


Patient contributions to benefit-risk decisions and the transparency of the process were discussed at the recent joint meeting of The Organisation for Professionals in Regulatory Affairs (TOPRA) and the European Medicines Agency (EMA).

The annual meeting took place in the EMA building in Canary Wharf, London, from November 24

Most read

Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story: